As part of the compromise, two of James Grenon’s former director nominees would get positions with the company.
The restructure at Building Products subsidiary Easysteel was revealed to union negotiators last week.
Outgoing CEO Kippenberger hails increasing revenue contribution from 'core' materials, minerals and protein markets.
The deal will create a Trans-Tasman business with forecast 2024 sales of A$400m.
While the offer was a premium on the recent shareprice the valuation was well below its A$455m peak in 2019.
Independent directors and experts Grant Samuels have both changed their views and believe Seven’s amended offer is now reasonable.
Forbar analysts cut earnings forecasts, despite predicting improved profits.
The NZX-listed medicinal cannabis firm went into voluntary administration late last month.
And some market participants question Sharesies’ role in promoting the offer.
Regulatory approval for its purchase of Challenger Bank is dependent on the $210m equity raise.